+20.1%
GSK vs TENB
-0.2%
+20.4%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | TENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -6.0% | +6.0% | -0.5% |
| 7D | -3.5% | -12.1% | +8.6% | -4.6% |
| 30D | -3.4% | -18.6% | +15.2% | -4.9% |
| 3M | -8.1% | +12.1% | -20.2% | -6.4% |
| 6M | -11.1% | +46.8% | -57.9% | -6.6% |
| YTD | +0.7% | +28.0% | -27.2% | +4.0% |
| 1Y | +20.1% | -1.4% | +21.5% | +11.6% |
| All | +20.1% | -0.2% | +20.4% | +11.6% |
Cumulative growth
Daily Returns
Daily percentage return beside TENB.
Daily Out/Under-Performance
Portfolio return minus TENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded TENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling